158 related articles for article (PubMed ID: 9537864)
1. Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver.
Caballería J; Parés A; Brú C; Mercader J; García Plaza A; Caballería L; Clemente G; Rodrigo L; Rodés J
J Hepatol; 1998 Jan; 28(1):54-60. PubMed ID: 9537864
[TBL] [Abstract][Full Text] [Related]
2. [Capsule metadoxine in the treatment of alcoholic liver disease: a randomized, double-blind, placebo-controlled, multicenter study].
Mao YM; Zeng MD; Li YM; Wang BY; Shang J; Shi RH; Liu JY; Lu LG; Cao AP
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):213-6. PubMed ID: 19335986
[TBL] [Abstract][Full Text] [Related]
3. Metadoxine in acute alcohol intoxication: a double-blind, randomized, placebo-controlled study.
Shpilenya LS; Muzychenko AP; Gasbarrini G; Addolorato G
Alcohol Clin Exp Res; 2002 Mar; 26(3):340-6. PubMed ID: 11923586
[TBL] [Abstract][Full Text] [Related]
4. [The therapeutic effect of metadoxine on alcoholic and non-alcoholic steatohepatitis].
Váli L; Blázovics A; Fehér J
Orv Hetil; 2005 Nov; 146(47):2409-14. PubMed ID: 16398154
[TBL] [Abstract][Full Text] [Related]
5. Treatment of alcoholic fatty liver: is the metabolic effect of metadoxine the only reason for improved liver function?
Stefanini GF; Addolorato G; Caputo F; Bernardi M; Gasbarrini G
J Hepatol; 1999 Apr; 30(4):739-40. PubMed ID: 10207820
[No Abstract] [Full Text] [Related]
6. [Treatment of alcoholic hepatic steatosis with metadoxine. Preliminary results on the evaluation of the effects of the drug by an ultrasonographic study].
Sergiacomo L; Ciancaglini R; Orlando D; Delle Monache G; Pesa O
Clin Ter; 1986 Oct; 119(2):133-41. PubMed ID: 3539468
[No Abstract] [Full Text] [Related]
7. Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease.
Leggio L; Kenna GA; Ferrulli A; Zywiak WH; Caputo F; Swift RM; Addolorato G
Hum Psychopharmacol; 2011 Dec; 26(8):554-9. PubMed ID: 22095793
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis and glycogen stores depletion induced by prolonged biliary obstruction in the rat are ameliorated by metadoxine.
Muriel P; Deheza R
Liver Int; 2003 Aug; 23(4):262-8. PubMed ID: 12895266
[TBL] [Abstract][Full Text] [Related]
9. [Effects of metadoxine on main biohumoral changes induced by chronic alcoholism].
Corsini G; Gelso E; Giuliano G
Clin Ter; 1992 Mar; 140(3):251-7. PubMed ID: 1568369
[TBL] [Abstract][Full Text] [Related]
10. Alcoholic abstinence syndrome: short-term treatment with metadoxine.
Bono G; Sinforiani E; Merlo P; Belloni G; Soldati M; Gelso E
Int J Clin Pharmacol Res; 1991; 11(1):35-40. PubMed ID: 1678735
[TBL] [Abstract][Full Text] [Related]
11. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity.
Ki SH; Choi JH; Kim CW; Kim SG
Chem Biol Interact; 2007 Aug; 169(2):80-90. PubMed ID: 17606256
[TBL] [Abstract][Full Text] [Related]
12. [Metadoxine in alcohol-related pathology].
Santoni S; Corradini P; Zocchi M; Camarri F
Clin Ter; 1989 Jul; 130(2):115-22. PubMed ID: 2529084
[TBL] [Abstract][Full Text] [Related]
13. Treatment with metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis.
Higuera-de la Tijera F; Servín-Caamaño AI; Cruz-Herrera J; Serralde-Zúñiga AE; Abdo-Francis JM; Gutiérrez-Reyes G; Pérez-Hernández JL
Ann Hepatol; 2014; 13(3):343-52. PubMed ID: 24756009
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic use of metadoxine in chronic alcoholism. Double blind study of patients in a department of general medicine].
Rizzo A; Breda A; Moretto F; Pace M; Dotta C; Gelso E; Sanzuol F; Tossani C
Clin Ter; 1993 Mar; 142(3):243-50. PubMed ID: 8482064
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder.
Manor I; Newcorn JH; Faraone SV; Adler LA
Postgrad Med; 2013 Jul; 125(4):181-90. PubMed ID: 23933905
[TBL] [Abstract][Full Text] [Related]
16. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder.
Manor I; Ben-Hayun R; Aharon-Peretz J; Salomy D; Weizman A; Daniely Y; Megiddo D; Newcorn JH; Biederman J; Adler LA
J Clin Psychiatry; 2012 Dec; 73(12):1517-23. PubMed ID: 23290324
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of metadoxine in the management of acute alcohol intoxication.
Díaz Martínez MC; Díaz Martínez A; Villamil Salcedo V; Cruz Fuentes C
J Int Med Res; 2002; 30(1):44-51. PubMed ID: 11921498
[TBL] [Abstract][Full Text] [Related]
19. Metadoxine in the treatment of acute and chronic alcoholism: a review.
Addolorato G; Ancona C; Capristo E; Gasbarrini G
Int J Immunopathol Pharmacol; 2003; 16(3):207-14. PubMed ID: 14611722
[TBL] [Abstract][Full Text] [Related]
20. Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial.
Shenoy KT; Balakumaran LK; Mathew P; Prasad M; Prabhakar B; Sood A; Singh SP; Rao NP; Zargar SA; Bignamini AA
J Clin Exp Hepatol; 2014 Jun; 4(2):94-100. PubMed ID: 25755546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
